SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: II. Equilibrium Analysis of Constant Infusion Experiments and Correlation with in vitro Parameters
暂无分享,去创建一个
Robert B. Innis | Marc Laruelle | Dennis S. Charney | Sami S. Zoghbi | Anissa Abi-Dargham | Ronald M. Baldwin | Paul B. Hoffer | D. Charney | M. Laruelle | A. Abi-Dargham | S. Zoghbi | R. Innis | R. Baldwin | Y. Zea‐Ponce | P. Hoffer | Yolanda Zea-Ponce | Mohammed S. AI-Tikriti
[1] Peter Herscovitch,et al. Journal of Cerebral Blood Flow and Metabolism Comparison of Bolus and Infusion Methods for Receptor Quantitation: Application to E8p]cyclofoxy and Positron Emission Tomography Cyclofoxy Infusion for Opiate Receptor Quant/tat/on Theory Compartment Models for Receptor-binding Radiotracers , 2022 .
[2] G R Wilkinson,et al. Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation. , 1989, The Journal of clinical investigation.
[3] R E Carson,et al. Regional Brain Measurement of Bmax and KD with the Opiate Antagonist Cyclofoxy: Equilibrium Studies in the Conscious Rat , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] Robert B. Innis,et al. SPECT Quantification of [123I]Iomazenil Binding to Benzodiazepine Receptors in Nonhuman Primates: I. Kinetic Modeling of Single Bolus Experiments , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] H. N. Wagner,et al. Multicompartmental Analysis of [11C]-Carfentanil Binding to Opiate Receptors in Humans Measured by Positron Emission Tomography , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] P B Hoffer,et al. Single photon emission tomography measurement of benzodiazepine receptor number and affinity in primate brain: a constant infusion paradigm with [123I]iomazenil. , 1993, European journal of pharmacology.
[7] Henry N. Wagner,et al. Kinetics of binding to opiate receptors in vivo predicted from in vitro parameters , 1984, Brain Research.
[8] M. Iyo,et al. Quantitative in vivo analysis of benzodiazepine binding sites in the human brain using positron emission tomography , 1991, Neuropharmacology.
[9] Marc Laruelle,et al. SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates , 1993, Synapse.
[10] M. Mintun,et al. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.
[11] K. Mullis,et al. Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model , 1980, Brain Research.
[12] E. Brouillet,et al. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography. , 1990, Molecular pharmacology.
[13] E. Sybirska,et al. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[14] B. W. Agranoff,et al. Quantitative in vivo receptor binding , 1986 .
[15] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[16] L. Farde,et al. Kinetic Analysis of Central [11C]Raclopride Binding to D2-Dopamine Receptors Studied by PET—A Comparison to the Equilibrium Analysis , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] S. Woods,et al. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154. , 1991, European journal of pharmacology.
[18] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .
[19] S. Zoghbi,et al. Formation of 1-[123I]iodobutane in labeling [123I]iomazenil by iododestannylation: implications for the reaction mechanism. , 1994, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[20] B L Holman,et al. Brain perfusion SPECT using an annular single crystal camera: initial clinical experience. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] J S Fowler,et al. Kinetic Modeling of Receptor‐Ligand Binding Applied to Positron Emission Tomographic Studies with Neuroleptic Tracers , 1987, Journal of neurochemistry.
[22] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[23] J. Baron,et al. Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[25] D Rodbard,et al. DESIGN: computerized optimization of experimental design for estimating Kd and Bmax in ligand binding experiments. I. Homologous and heterologous binding to one or two classes of sites. , 1988, Analytical biochemistry.
[26] E. Sybirska,et al. SPECT Imaging of the benzodiazepine receptor: Autoradiographic comparison of receptor density and radioligand distribution , 1992, Synapse.